2016

10732 bookmarks
Custom sorting
Cellular Fragility Syndrome & C15:0 Deficiency – fatty15
Cellular Fragility Syndrome & C15:0 Deficiency – fatty15
A big paper was just published on a newly discovered nutritional C15:0 deficiency syndrome, called Cellular Fragility Syndrome. This is a big deal because nutritional deficiency syndromes (like vitamin C deficiency and scurvy, or vitamin D deficiency and rickets) are rarely discovered. This latest paper describes how d
·fatty15.com·
Cellular Fragility Syndrome & C15:0 Deficiency – fatty15
Fatty15 Patent Positioning: Our Moral & Legal Responsibilities – fatty15
Fatty15 Patent Positioning: Our Moral & Legal Responsibilities – fatty15
Years ago, while helping to continually improve the health and welfare of aging Navy dolphins, our fatty15 founders discovered C15:0 (aka pentadecanoic acid) as the first essential fatty acid to be identified since omega-3, which was over 90 years ago. For more on our founding story, check out our idea-worth-sharing TE
·fatty15.com·
Fatty15 Patent Positioning: Our Moral & Legal Responsibilities – fatty15
Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health | Scientific Reports
Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health | Scientific Reports
Scientific Reports - Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health
·nature.com·
Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health | Scientific Reports
US11116740B2 - Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome - Google Patents
US11116740B2 - Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome - Google Patents
Compositions including an odd chain fatty acid, and salts and derivatives thereof, and methods for metabolic syndrome treatment and prophylaxis are provided, including compositions and methods for treating diabetes, obesity, hyperferritinemia, elevated insulin, glucose intolerance, dyslipidemia and related conditions. Methods for the diagnosis and monitoring of metabolic syndrome are also provided.
·patents.google.com·
US11116740B2 - Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome - Google Patents
Kimera Labs
Kimera Labs
Leading exosome biotechnology laboratory. Specializes in the production of perinatal MSC-derived exosome products for cosmetic treatment. Request a lab tour.
·kimeralabs.com·
Kimera Labs
Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds - PMC
Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds - PMC
Pentadecanoic acid (C15:0) is an essential odd-chain saturated fatty acid with broad activities relevant to protecting cardiometabolic, immune, and liver health. C15:0 activates AMPK and inhibits mTOR, both of which are core components of the human ...
·pmc.ncbi.nlm.nih.gov·
Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds - PMC
Kimera Labs
Kimera Labs
Leading exosome biotechnology laboratory. Specializes in the production of perinatal MSC-derived exosome products for cosmetic treatment. Request a lab tour.
·kimeralabs.com·
Kimera Labs
Kimera Labs
Kimera Labs
Leading exosome biotechnology laboratory. Specializes in the production of perinatal MSC-derived exosome products for cosmetic treatment. Request a lab tour.
·kimeralabs.com·
Kimera Labs